Home
About
Overview
Sharing Data
ORCID
Help
History (44)
A spectroscopic analysis of low-fluorescent mutants of Chlamydomonas reinhardti blocked in their water-splitting oxygen-evolving apparatus.
Peroxynitrous Acid
Delayed antagonism of calpain reduces excitotoxicity in cultured neurons.
Myosin light chain kinase steady-state kinetics: comparison of smooth muscle myosin II and nonmuscle myosin IIB as substrates.
Emerging biologic therapies in inflammatory bowel disease.
See All 44 Pages
Find People
Find Everything
Login
to edit your profile (add a photo, awards, links to other websites, etc.)
Edit My Profile
My Person List (
0
)
Return to Top
Emerging biologic therapies in inflammatory bowel disease.
Emerging biologic therapies in inflammatory bowel disease. Rev Gastroenterol Disord. 2004; 4(2):66-85.
View in:
PubMed
subject areas
Antibodies, Monoclonal
Biological Therapy
Colitis, Ulcerative
Crohn Disease
Female
Forecasting
Gastrointestinal Agents
Humans
Inflammatory Bowel Diseases
Infliximab
Male
Prognosis
Randomized Controlled Trials as Topic
Severity of Illness Index
Treatment Outcome
authors with profiles
Stephen B. Hanauer